[ Gamida Cell raises $40M in Venture ]

Gamida Cell has raised  $40 million in Venture.

Founded in 1998, Gamida Health is a developer of cellular and immune therapies for the treatment of cancer and orphan genetic diseases.

The new funding will support Gamida Cell’s Phase 3 trial of its NiCord bone marrow transplantation product.

Funding  Venture
Founded  1998
Country  Israel
City  Gerusalem, Jerusalem District
Founder / CEO  Yael Margolin
Deal Size  $40M
Investors  Clal Biotechnology Industries
 Shavit Capital
 VMS Investment Group
 Israel Biotech Fund
 Israel Healthcare Ventures
Previous Investors  Denali Ventures
 Israel Innovation Authority
 Teva Pharmaceutical Industries
 Elscint Biomedical Investment
 Auriga Partners
 Amgen Ventures
 Israel Healthcare Ventures
 Clal Biotechnology
 Biomedical Investments